Redox imbalance induced by docetaxel in the neuroblastoma SH-SY5Y cells: a study of docetaxel-induced neuronal damage
Open Access
- 1 January 2021
- journal article
- research article
- Published by Taylor & Francis Ltd in Redox Report
- Vol. 26 (1), 18-28
- https://doi.org/10.1080/13510002.2021.1884802
Abstract
In cancer survivors, chemotherapy-associated adverse neurological effects are described as side effects in non-targeted tissue. We investigated the role of redox-imbalance in neuronal damage by a relative low dose of Docetaxel (DTX). The neuroblastoma cells (SH-SY5Y cells) were exposed to DTX at a dose of 1.25 nM for 6 h. Antioxidant defenses (i.e. ascorbic acid, glutathione, and catalase) and lipid oxidation products (i.e. F2-isoprostanes) were evaluated. To investigate cell ultrastructure and tubulin localisation, transmission electron microscopy (TEM) and immunofluorescence techniques were applied. In the SH-SY5Y cells, DTX induced a significant reduction of total glutathione (P < 0.001) and ascorbic acid (P < 0.05), and an increase in both total F2-Isoprostanes (P < 0.05) and catalase activity (P < 0.05), as compared to untreated cells. Additionally, TEM showed a significant increase in cells with apoptotic characteristics. Immunolocalisation of tubulin showed a compromised cytoskeletal organisation. The investigated sublethal dose of DTX, to which non-targeted cells may be exposed throughout the duration of chemotherapy treatment, induces a redox imbalance resulting in a specific modulation of the antioxidant response. This study provides new insights into DTX-induced cellular mechanisms useful for evaluating whether the concomitant use of antioxidants associated with chemotherapy mitigates chemotherapy side effects in cancer survivors.Keywords
Funding Information
- Plan of Research Support 2019
- University of Siena
This publication has 73 references indexed in Scilit:
- A Protocol for Quantifying Lipid Peroxidation in Cellular Systems by F2-Isoprostane AnalysisPLOS ONE, 2013
- Cognitive side effects of cancer therapy demonstrate a functional role for adult neurogenesisBehavioural Brain Research, 2012
- Impact of Breast Cancer and Combination Chemotherapy on Oxidative Stress, Hepatic and Cardiac MarkersJournal of Breast Cancer, 2012
- An Update on Cancer- and Chemotherapy-Related Cognitive Dysfunction: Current StatusSeminars in Oncology, 2011
- 2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-α release: Implications for the reactive oxygen species-mediated mechanisms of chemobrainFree Radical Biology & Medicine, 2011
- Drugs that target dynamic microtubules: A new molecular perspectiveMedicinal Research Reviews, 2011
- Chemotherapy‐induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patientsHuman Brain Mapping, 2011
- Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5–10 years after chemotherapyBreast Cancer Research and Treatment, 2006
- Improved penetration of docetaxel into the brain by co-administration of inhibitors of P-glycoproteinEuropean Journal of Cancer, 2004
- Cytotoxicity of paclitaxel and docetaxel in human neuroblastoma cell linesEuropean Journal of Cancer, 1995